0001144204-19-001393.txt : 20190110 0001144204-19-001393.hdr.sgml : 20190110 20190110211423 ACCESSION NUMBER: 0001144204-19-001393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190108 FILED AS OF DATE: 20190110 DATE AS OF CHANGE: 20190110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bendheim Daniel M CENTRAL INDEX KEY: 0001601576 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 19521331 MAIL ADDRESS: STREET 1: 300 FRANK W. BURR BOULEVARD STREET 2: SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER NAME: FORMER CONFORMED NAME: Bendheim Daniel M. DATE OF NAME CHANGE: 20140303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 4 1 tv510834_4.xml FORM 4 X0306 4 2019-01-08 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001601576 Bendheim Daniel M 300 FRANK W. BURR BOULEVARD SUITE 21 TEANECK NJ 07666 1 1 0 0 Exec. VP, Corporate Strategy Class A Common Stock 2019-01-08 4 M 0 2500 11.83 A 2500 D Class A Common Stock 2019-01-08 4 S 0 2500 32.31 D 0 D Class A Common Stock 2019-01-09 4 M 0 2500 11.83 A 2500 D Class A Common Stock 2019-01-09 4 S 0 2500 32.54 D 0 D Option to purchase Common Stock 11.83 2019-01-08 4 M 0 2500 0 D 2013-03-01 2019-02-28 Class A Common Stock 2500 7390 D Option to purchase Common Stock 11.83 2019-01-09 4 M 0 2500 0 D 2013-03-01 2019-02-28 Class A Common Stock 2500 4890 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. /s/ Thomas G. Dagger, as Attorney-in-Fact for Daniel M. Bendheim 2019-01-10